Normax current engagements:
Stakeholders
- SINTEF Strategic R&D Partner
- Strategic Technology Vendors and Partners; AFRY, Cytiva, Emtunga, IQVIA, Merck, Syntegon, Watson-Marlow, WSP
- mRNA UCV Consortium by NORMAX (ECAM Vaccines Limited)
- Private Investors
Support by Norwegian Government Organizations
- Commercialization grant by Innovasjonnorge (Innovation Norway)
Pharmaceutical Industry Membership
NOT AN OFFER TO INVEST.
SEE RED HERRING DISCLAIMER.